参考文献/References:
[1] Chargaff E, West R. The biological significance of the
thromboplastic protein of blood [J]. J Biol Chem, 1946, 166
(1): 189-197.
[2] Johnstone RM, Adam M, Hammond JR, et al. Vesicle forma-
tion during reticulocyte maturation: association of plasma
membrane activities with released vesicles (exosomes) [J].
J Biol Chem, 1987, 262: 9412-9420.
[3] Whiteside TL. Exosomes and tumor-mediated immune sup-
pression [J]. J Clin Invest, 2016, 126(4): 1216-1223.
[4] Kalluri R. The biology and function of exosomes in cancer
[J]. J Clin Invest, 2016, 126(4): 1208-1215.
[5] Ferris SP, Hofmann JW, Solomon DA, et al. Characterization
of gliomas: from morphology to molecules [J]. Virchows
Arch, 2017, 471(2): 471- 257.
[6] Domenis R, Cesselli D, Toffoletto B, et al. Systemic T cells
immunosuppression of glioma stem cell-derived exosomes
is mediated by monocytic myeloid-derived suppressor cells
[J]. PLoS One, 2017, 12(1): e0169932.
[7] 张国滨，聂秀涛，张昀昇，等. 不同氧环境下胶质瘤干细胞
源性外泌体携带miRNAs对肿瘤增殖作用的研究[J]. 中
华神经外科杂志，2017，33（5）：508-512.
[8] Ma C, Nguyen H, Paradiso L, et al. P08. 35 Exosomes de-
rived from glioma stem cells (GSCs) promote cell migration,
proliferationand radiation resistance in brain cancer [J].
Neuro Oncol, 2017, 19(suppl 3): iii61.
[9] Kucharzewska P, Christianson HC, Welch JE, et al. Exo-
somes reflect the hypoxic status of glioma cells and mediate
hypoxia-dependent activation of vascular cells during
tumor development [J]. Proc Natl Acad Sci USA, 2013, 110
(18): 7312-7317.
[10] Zheng L, Li Z, Ling W, et al. Exosomes derived from den-
dritic cells attenuate liver injury by modulating the balance
of Treg and Th17 cells after ischemia reperfusion [J]. Cell
Physiol Biochem, 2018, 46(2): 740-756.
[11] 杨建凯，齐雪姣，焦保华，等. GBM细胞来源外泌体促进
小胶质细胞介导的炎症反应[J]. 河北医科大学学报，
2018，39（11）：1311-1315.
[12] Suehiro T, Miyaaki H, Kanda Y, et al. Serum exosomal
microRNA122 and microRNA21 as predictive biomarkers
in transarterial chemoembolizationtreated hepatocellular
carcinoma patients [J]. Oncol Lett, 2018, 19(6): 3267-3273
[13] Yeung TP, Bauman G, Yartsev S, et al. Dynamic perfusion
CT in brain tumors [J]. Eur J Radiol, 2015, 84(12): 2386-
2392.
[14] Yamamoto Y, Ono Y, Aga F, et al. Correlation of 18F-FLT
uptake with tumor grade and Ki-67 immunohistochemistry
in patients with newly diagnosed and recurrent gliomas [J].
J Nucl Med, 2012, 53(12): 1911-1915.
[15] Malzkorn B, Reifenberger G. Practical implications of
integrated glioma classification according to the World
Health Organization classification of tumors of the central
nervous system 2016 [J]. Curr Opin Oncol, 2016, 28(6):
494-501.
[16] Hirano M, Ohka F, Maeda S, et al. A novel high-sensitivity
assay to detect a small fraction of mutant IDH1 using drop-
let digital PCR [J]. Brain Tumor Pathol, 2018, 35(2): 1-9.
[19] Bush NAO , Butowski N. The effect of molecular diagnostics
on the treatment of glioma [J]. Curr Oncol Rep, 2017, 19(4):
26.
[20] Hole P, Sillence K, Hannell C, et al. Interlaboratory compa-
rison of size measurements on nanoparticles using nanopar-
ticle tracking analysis (NTA) [J]. J Nanopart Res, 2013, 15
(12): 2101-2112.
[21] Neal A, Kwan P, O'Brien TJ, et al. IDH1 and IDH2 muta-
tions in postoperative diffuse glioma-associated epilepsy [J].
Epilepsy Behavior, 2018, 78: 30-36.
[22] Lin P, Luo Y, Zhu S, et al. Isocitrate dehydrogenase 2 muta
tions correlate with leukemic transformation and are predic-
ted by 2-hydroxyglutarate in myelodysplastic syndromes [J].
J Cancer Res Clin Oncol, 2018, 144(6): 1037-1047.
[23] Jones PS, Dunn GP, Barker FG, et al. Molecular genetics of
low-grade gliomas: genomic alterations guiding diagnosis
and therapeutic intervention: 11th Annual Frye-Halloran
Brain Tumor Symposium [J]. Neurosurg Focus, 2013, 34(2):
E9.
[24] Akers JC, Ramakrishnan V, Kim R, et al. miR-21 in the
extracellular nesicles (EVs) of cerebrospinal fluid (CSF): a
platform for glioblastoma biomarker development [J]. Plos
One, 2013, 8(10): e78115.
相似文献/References:
[1]王振宇.脊髓髓内肿瘤诊断与治疗中若干问题的讨论[J].中国临床神经外科杂志,2015,(11):641.[doi:10.13798/j.issn.1009-153X.2015.11.001]
[2]王在贵 张新元 杨 铭 潘 力 李国栋 刘 征 伍 杰 马廉亭.MRI、320-CTA及DSA在脊髓血管病诊断中的应用[J].中国临床神经外科杂志,2015,(11):643.[doi:10.13798/j.issn.1009-153X.2015.11.002]
WANG Zai-gui,ZHANG Xin-yuan,YANG Ming,et al.Value of MRI, 320-CTA and DSA to diagnosis of spinal vascular disease[J].,2015,(02):643.[doi:10.13798/j.issn.1009-153X.2015.11.002]
[3]于 涛 黄正通 王振宇.椎管内脊膜囊肿的临床特征和治疗方法[J].中国临床神经外科杂志,2015,(11):654.[doi:10.13798/j.issn.1009-153X.2015.11.005]
YU Tao,HUANG Zheng-tong,WANG Zhen-yu.Clinical features and treatment of intraspinal arachnoid cysts[J].,2015,(02):654.[doi:10.13798/j.issn.1009-153X.2015.11.005]
[4]柳 羲 张 帆 田勤力 刘 利.成人幕上原始神经外胚层肿瘤3例报道及文献复习[J].中国临床神经外科杂志,2015,(11):689.[doi:10.13798/j.issn.1009-153X.2015.11.016]
[5]刘 阳 连 伟 综述 王任直 校审.垂体泌乳素腺瘤诊疗中常见问题及解决方案[J].中国临床神经外科杂志,2015,(11):698.[doi:10.13798/j.issn.1009-153X.2015.11.020]
[6]敖祥生 胡克琦.血管内治疗椎动脉夹层动脉瘤14例临床分析[J].中国临床神经外科杂志,2016,(05):302.[doi:10.13798/j.issn.1009-153X.2016.05.016]
[7]马廉亭.SDAVF与SPAVF的诊治与鉴别[J].中国临床神经外科杂志,2016,(07):385.[doi:10.13798/j.issn.1009-153X.2016.07.001]
[8]符传艺 陈健龙 张 茂 刘朝晖 黄垂学 黄 军 马建荣 赵建农.表现为脑室出血的颅内破裂动脉瘤的诊治[J].中国临床神经外科杂志,2016,(04):234.[doi:10.13798/j.issn.1009-153X.2016.04.014]
[9]周长帅 任志伟 综述 遇 涛 李勇杰 审校.岛叶癫痫症状学研究进展周长[J].中国临床神经外科杂志,2016,(04):249.[doi:10.13798/j.issn.1009-153X.2016.04.021]
[10]肖连福 黄瑞宏 陈昌勇.外伤性颅内静脉窦血栓形成1例[J].中国临床神经外科杂志,2016,(04):256.[doi:10.13798/j.issn.1009-153X.2016.04.024]
[11]刘江涛 综述 陈谦学 审校.磁共振灌注成像技术在脑胶质瘤诊疗中的应用进展[J].中国临床神经外科杂志,2020,(04):248.[doi:10.13798/j.issn.1009-153X.2020.04.020]
[12]胡旭磊 何 涛 孙胜玉 邹有瑞 马 辉.氢质子磁共振波谱成像在脑胶质瘤诊断中的研究进展[J].中国临床神经外科杂志,2020,(07):485.[doi:10.13798/j.issn.1009-153X.2020.07.025]